Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Mirum Pharmaceuticals Inc. (MIRM)

16.9   -0.16 (-0.94%) 02-14 16:00
Open: 17.11 Pre. Close: 17.06
High: 17.9 Low: 16.74
Volume: 67,731 Market Cap: 418M
Mirum Pharmaceuticals, Inc., a clinical-stage therapeutics company, develops and produces therapies for patients with cholestatic liver diseases with a focus on rare pediatric conditions. The company's lead product candidate is maralixibat, a Phase 3-ready investigational oral drug with indications, including Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC). It is also developing Volixibat, an investigational oral inhibitor of ASBT, a protein that is primarily responsible for recycling bile acids from the intestine to the liver. The company was incorporated in 2018 and is based in Foster City, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 17.926 - 18.017 18.017 - 18.091
Low: 16.541 - 16.632 16.632 - 16.707
Close: 16.766 - 16.909 16.909 - 17.027

Technical analysis

as of: 2020-02-14 4:30:44 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 22.83     One year: 26.00
Support: Support1: 15.15    Support2: 12.60
Resistance: Resistance1: 19.55    Resistance2: 22.26
Pivot: 16.78
Moving Average: MA(5): 16.82     MA(20): 17.36
MA(100): 13.08     MA(250):
MACD: MACD(12,26): -0.48     Signal(9): -0.43
Stochastic oscillator: %K(14,3): 39.18     %D(3): 35.67
RSI: RSI(14): 47.24
52-week: High: 28.31  Low: 6.51  Change(%): 27.9
Average Vol(K): 3-Month: 38159  10-Days: 9197

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
MIRM has closed below upper band by 45.9%. Bollinger Bands are 51.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to MIRM's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mirum Pharmaceuticals Promotes Ian Clements to Chief Financial Officer
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating liver diseases, today announced the promotion of Ian Clements to Chief Financial Officer. Dr. Clements joined Mirum in March 2019 and most recently served as Senior Vice President, Finance and Communications. “Since joining Mirum, Ian has played a pivotal role in the growth and success of the company,”

Mirum Pharmaceuticals Announces Pricing of Public Offering
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating liver diseases, today announced the pricing of its public offering of 2,400,000 shares of its common stock at a price to the public of $20.00 per share. The gross proceeds to Mirum from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 24.99
Shares Float (M) 4.87
% Held by Insiders 10.29
% Held by Institutions 75.10
Shares Short (K) 112
Shares Short P. Month (K)

Stock Financials

EPS -9.330
Book Value (p.s.) 6.480
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -26.20
Levered Free Cash Flow (M)

Stock Valuations

P/E -1.81
P/E Growth Ratio -0.01
P/BV 2.61
P/CF -16.12

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.